Tennessee 2023-2024 Regular Session

Tennessee Senate Bill SJR0044

Introduced
1/20/23  
Engrossed
2/27/23  
Refer
3/2/23  
Refer
3/14/23  
Refer
3/22/23  
Enrolled
4/4/23  

Caption

A RESOLUTION relative to improving the care of atherosclerotic cardiovascular disease.

Impact

The resolution urges state agencies to expand comprehensive cardiovascular screening programs. These programs are intended to facilitate earlier identification of patients at risk of cardiovascular events, thereby potentially reducing the incidence of ASCVD-related deaths and complications. Furthermore, it advocates for collaboration with federal and national agencies to enhance cardiovascular care and calls for an update to the state’s cardiovascular plan, aiming to accelerate quality improvements in diagnosis, treatment, and monitoring of patients. By implementing these measures, the resolution seeks to alleviate the burden of ASCVD on the healthcare system and improve overall public health outcomes in Tennessee.

Summary

SJR0044 is a Senate Joint Resolution aimed at improving the care and management of atherosclerotic cardiovascular disease (ASCVD) in Tennessee. The resolution highlights the significant impact of cardiovascular disease, which is the leading cause of death in the United States, and underscores the importance of addressing the high prevalence of ASCVD, particularly in Tennessee where substantial medical costs and a projection of escalating numbers are at stake. It acknowledges the alarming rates of high low-density lipoprotein cholesterol (LDL-C) among adults, which is a contributing factor to ASCVD, and calls for action to better manage these health risks.

Contention

While the resolution has garnered support due to its public health focus, some may argue about the feasibility of implementing widespread screening programs amid existing healthcare constraints. Critics could also point to the broad scope of collaboration required with federal entities and the challenge of sustaining funding for such initiatives. Additionally, the resolution's advocacy for policy creation to address the rising deaths from ASCVD signals a need for careful consideration of existing healthcare policies and potential legislative adjustments, which could become points of debate among lawmakers and constituents alike.

Companion Bills

No companion bills found.

Previously Filed As

TN HB8260

Cardiovascular Disease Early Detection and Prevention Act of 2026

TN SR464

A resolution designating September 2025 as "National Cholesterol Education Month" and September 30, 2025, as "LDL-C Awareness Day".

TN SB2744

Relating to the modernization of cardiovascular screening and prevention under the Texas Heart Attack Prevention Bill.

TN HR0010

Recognizing women's heart health research and supporting awareness for cardiovascular disease.

TN HJR464

Cardiovascular disease screening coverage; Health Insurance Reform Commission to study.

TN HB2485

Relating To Cardiovascular Screening.

TN SR562

A resolution recognizing that ozone pollution can cause lung disease, asthma attacks, cardiovascular problems, and reproductive issues.

TN HB163

An Act To Amend Title 29 Of The Delaware Code Relating To The Delaware Diabetes Wellness Pilot Program Within The Department Of Human Resources To Study Prediabetic And Diabetic Well Care.

TN HR619

Minority Health Month; April 2025; encourage cholesterol screening; recognize

TN SB130

No Cost-sharing Of Certain Drugs

Similar Bills

No similar bills found.